NNC0268-0965

DRUG3 trials

Sponsors

Novo Nordisk A/S

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Healthy Volunteers

Phase 1

A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes

CompletedNCT03965013

Novo Nordisk A/SDiabetes Mellitus, Type 1, Healthy Volunteers

Start: 2019-06-05End: 2019-12-14Updated: 2021-01-14

A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes

CompletedNCT04136067

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2019-10-29End: 2020-08-23Updated: 2022-09-08

A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine

CompletedNCT04575181

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2020-10-21End: 2021-12-24Updated: 2024-01-10